Risk of Liver Fibrosis in Patients With Psoriasis on Long-term Methotrexate: Role of Cumulative Dose and Comorbidities in 483 Patients
- 6 June 2025
- journal article
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 15 (6) , 102606
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Liver fibrosis with methotrexate — an overestimated risk?Nature Reviews Gastroenterology & Hepatology, 2023
- Methotrexate-induced liver fibrosis: The end of a long-held beliefJournal of Hepatology, 2023
- Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimatedJournal of Hepatology, 2023
- Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell functionDiabetologia, 2022
- Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based studyJournal of the American Academy of Dermatology, 2021
- Prevalence of Advanced Liver Fibrosis in Patients With Severe PsoriasisJAMA Dermatology, 2019
- Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based StudyJournal of Investigative Dermatology, 2018
- Systematic review and meta-analysis of the association between psoriasis and metabolic syndromeJournal of the American Academy of Dermatology, 2017
- Diagnosis of Fibrosis and Cirrhosis Using Liver Stiffness Measurement in Nonalcoholic Fatty Liver DiseaseHepatology, 2010
- Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatmentJournal of Hepatology, 2007